DANIEL B SOLAND
CIK 1318485 · CHIEF OPERATING OFFICER · last filed 2025-06-02
DANIEL B SOLAND is a CHIEF OPERATING OFFICER who has filed 53 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for ACAD, was dated Jun 2, 2025. Across all open-market trades the lifetime net is +$169.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.55M
5
53
$169.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACAD | Director | 44,041 | $21.09 | $928.8K | $234.9K | 14 | 2025-06-02 |
| DBVT | Director | 20,000 | $17.41 | $348.3K | $24.3K | 2 | 2023-08-03 |
| Aceragen, Inc. (IDRA) Delisted | CHIEF OPERATING OFFICER | 78,843 | $7.22 | $569.6K | $98.5K | 7 | 2022-07-07 |
| KALV | Director | 10,000 | $27.00 | $270.0K | $118.7K | 5 | 2021-10-01 |
| VIROPHARMA INC (VPHM) Delisted | VP, Chief Operating Officer | 148,188 | — | — | -$306.6K | 24 | 2014-01-10 |
Recent Filings
53 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-02 | ACAD | Mixed | +9,387 | $0 | EDGAR |
| 2024-05-31 | ACAD | Mixed | +6,652 | $0 | EDGAR |
| 2023-08-03 | DBVT | Buy (P) | +15,000 | $24.3K | EDGAR |
| 2023-06-05 | ACAD | Mixed | +18,002 | $0 | EDGAR |
| 2022-07-07 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | ACAD | Grant (A) | — | $0 | EDGAR |
| 2022-04-04 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-26 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-01 | KALV | Grant (A) | — | $0 | EDGAR |
| 2021-07-12 | Aceragen, Inc. (IDRA) Delisted | Grant (A) | — | $0 | EDGAR |